PROCESS FOR PRODUCTION OF DERIVATIVES OF 7-OXO-PROSTACYCLIN WITH SELECTIVE BIOLOGICAL EFFECT

Compounds of the formula I are disclosed wherein R1 stands for hydrogen, C1-4 straight or branched alkyl or pharmacologically acceptable cation, R2 stands for hydrogen, C1-4 alkanoyl, benzoyl, or benzoyl substituted by C1-4 alkyl or halogen, and R2 can further represent tetrahydropyranyl, trialkylsi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: IVANICS,JOZSEF,HU, VIRAG,SANDOR,HU, GALAMBOS,GEZA,HU, KOERMOECZY,PETER,HU, TOEMOESKOEZI,ISTVAN,HU, KOVACS,MARIANN,HU, STADLER,ISTVAN,HU, KOVACS,GABOR,HU, GYOERI,PETER,HU, KANAI,KAROLY,HU, DORMAN,GYOERGY,HU
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Compounds of the formula I are disclosed wherein R1 stands for hydrogen, C1-4 straight or branched alkyl or pharmacologically acceptable cation, R2 stands for hydrogen, C1-4 alkanoyl, benzoyl, or benzoyl substituted by C1-4 alkyl or halogen, and R2 can further represent tetrahydropyranyl, trialkylsilyl or alkoxyalkyl, A stands for ethylene, cis or trans-vinylene or -C=C-, n may represent 2, 3 or 4. The compounds are highly effective in the inhibition of thrombocyte aggregation while at the same time exert only a very small hypotensive effect.